Conray Injection
Product Images NDC 0019-0953

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Conray (NDC 0019-0953). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Liebel-flarsheim Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Conray 1)

FDA Label Image

Principal Display Panel (Conray 2)

Principal Display Panel (Conray 2)
This is a description for Conray, a sterile solution manufactured by Liebel-Flarsheim Company LLC, for intravascular use. It contains iothalamate meglumine Injection USP 60%. Each mL has 600mg iothalamate meglumine, 0.09mg edetate calcium disodium as a stabilizer, and 0.125mg monobasic sodium phosphate as a buffer. It is not for intrathecal use and must be protected from light. The package insert contains instructions for the usual dosage, and any unused portion in the single-dose container should be discarded. The label shows information on NDC, DAN, and other manufacturing details.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.